genprowebdirectory
GEN Edge
News
Insights
Trends for 2021
Trends for 2020
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Get GEN Edge
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
GEN Edge
OMICs
From Genomes to Drugs: An Interview with Vertex CSO David Altshuler
Gene Therapy
AI Gets Gene Therapy Over the Immunity Hump
Coronavirus
Immunai Expands from Observational to Functional Genomics
Antibody Drug Conjugates
RNA in Its DNA: Avidity Biosciences Combines mAb Selectivity, Oligonucleotide Precision
mRNA
OliX Advancing in Nucleic Acid Therapeutics
News
Cancer
Blocking a Treg Mechanism Can Scorch Tumors without Stoking Autoimmunity
Genome Editing
Now on Base, Rutgers Team Reveals New Genome Editing Approach
News
Phage Therapy Successful in Mice, but Resistance Looms
OMICs
Cellular Health Maintenance System Degradation May Lead to Advanced Huntington’s
News
Atopic Dermatitis Potentially Treated by Strain of Bacteria
Insights
All
Trends for 2021
Trends for 2020
Bioprocessing
COVID-19 Increasing Risk of Cyberattacks for Digital Biopharma
Bioprocessing
Case Study: How to Accelerate COVID-19 Vaccine Development
Bioprocessing
Flexibility is Key to Advances in Biomanufacturing
Bioprocessing
People Are Key to the Digital Evolution of Biopharma
A-Lists
January 2021 Vol. 41 No. 1
Seven Biopharma Trends to Watch in 2021
A-Lists
Top 15 Best-Selling Drugs Launched in 2020
A-Lists
Top 50 NIH-Funded Institutions of 2020
July 2020 Vol. 40 No. 7
Top 10 Earners among Women Biopharma Executives
June 2020 Vol. 40 No. 6
In Praise of Lesser-Sung Life Sciences Clusters
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Cancer
Blocking a Treg Mechanism Can Scorch Tumors without Stoking Autoimmunity
OMICs
From Genomes to Drugs: An Interview with Vertex CSO David Altshuler
Upcoming Webinars
Solving Metadata Management from Sample Provenance through Omics
Bioprocessing
COVID-19 Increasing Risk of Cyberattacks for Digital Biopharma
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Home
RNA
mRNA
mRNA
Most popular
Latest
Featured posts
Most popular
7 days popular
By review score
Random
mRNA
Optimize Protein Glycosylation—and—Yield by In Vitro Glycoengineering
mRNA
Development to Manufacturing: Considerations for Optimizing mRNA Production
mRNA
Novel Nano System Delivers mRNA to Inflammatory Leukocytes
mRNA
More Manageable Telomere Extension, Thanks to Modified mRNA
mRNA
Regulus Axing 60% of Workforce, Pauses Patient Recruitment for Lead Program
mRNA
Hardening of the RNA Condensates May Solidify Neurodegeneration
mRNA
Rogue Ribosomes Defy Stop Signals, Go to Work in Untranslated Regions
mRNA
Stopping Premature Protein Synthesis Halts Genetic Diseases
mRNA
Looking-Glass Nucleic Acid Zymes Promise RNA-Editing Wonderland
mRNA
Moderna Files for Largest-Ever Biotech IPO, Seeking to Raise $500M
mRNA
U.S. Raises to $2.5B toward Its “Warp Speed” Bet on Moderna’s...
mRNA
Lyme Disease May Be Diagnosable via Transcriptome Signature
mRNA
BioNTech Plans Pipeline, Platform Expansion with IPO Proceeds
mRNA
Molecular Underpinnings of Memory Now Better Understood
mRNA
Stem Cells in Body Transcriptionally Distinct from Those Extracted for Study
1
2
3
...
8
Page 1 of 8
Scroll Up
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
/* The alert message box */ .alert { padding: 20px; background-color: #ff9800; /* Red */ color: white; margin-bottom: 15px; } /* The close button */ .closebtn { margin-left: 15px; color: white; font-weight: bold; float: right; font-size: 22px; line-height: 20px; cursor: pointer; transition: 0.3s; } /* When moving the mouse over the close button */ .closebtn:hover { color: black; } .td_module_flex_2 .entry-title { font-size: 17px; line-height: 20px; }
![Atomic models proposed for the L-hammerhead ribozyme and the L-DNAzyme interacting with their target D-RNA. [Volker A. Erdmann et al.]](https://www.genengnews.com/wp-content/uploads/2018/08/MirrorImageZymes_FreeUniOfBerlin1071156617-324x160.jpg "Looking-Glass Nucleic Acid Zymes Promise RNA-Editing Wonderland")
